This report provides an overview of the therapeutic area and market size for the 7 major markets.

Executive Summary

• Addressable Patient Pool
• Major Players in the Market
• Market Dynamics
• Market Forecast

Disease Understanding

• Overview
• Etiology
• Symptoms
• Diagnostic Algorithm
• Treatment Algorithm
• Current Standard of Care

7MM Epidemiology Overview

• United States: Epidemiology Outlook
  • Disease Burden
  • Patient Demographics
  • Diagnosed Patient Pool
  • Treatable Patient Pool
  • Epidemiology Forecast
• EU-5 Countries: Epidemiology Outlook
  • Germany Epidemiology Size
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
  • France Epidemiology Size
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
  • Italy Epidemiology Size
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
  • Spain Epidemiology Size
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
  • United Kingdom Market Outlook
    • Disease Burden
    • Patient Demographics
    • Diagnosed Patient Pool
    • Treatable Patient Pool
    • Epidemiology Forecast
• Japan Market Outlook
  • Disease Burden
  • Patient Demographics
  • Diagnosed Patient Pool
  • Treatable Patient Pool
  • Epidemiology Forecast

Unmet Needs

Emerging Therapies

• Competitive Landscape
• Pipeline Benchmarking
• Key Product Profiles
• Durvalumab: AstraZeneca
  • Product Description
  • Regulatory Milestones
  • Clinical Development
  • Safety and efficacy
• Cemiplimab: Regeneron/ Sanofi
  • Product Description
  • Regulatory Milestones
  • Clinical Development
  • Safety and efficacy

7MM Market Analysis

• Key Insights
• Market Forecast Assumptions
• Market Size of Non-Small Cell Lung Cancer (NSCLC) in 7MM countries
• Market Size of Non-Small Cell Lung Cancer (NSCLC) by therapies in 7MM
• United States: Market Outlook
  • Total Market size of Non-Small Cell Lung Cancer (NSCLC) in the US
  • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in the US
• EU-5 Countries: Market Outlook
  • Germany Market Size
    • Total Market Size of Non-Small Cell Lung Cancer (NSCLC) in Germany
    • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in Germany
  • France Market Size
    • Total Market Size of Non-Small Cell Lung Cancer (NSCLC) in France
    • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in France
  • Italy Market Size
    • Total Market Size of Non-Small Cell Lung Cancer (NSCLC) in Italy
    • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in Italy
  • Spain Market Size
    • Total Market Size of Non-Small Cell Lung Cancer (NSCLC) in Spain
    • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in Spain
  • United Kingdom Market Size
    • Total Market Size of Non-Small Cell Lung Cancer (NSCLC) in the UK
    • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in the UK
• Japan Market Outlook
  • Total Market Size of Non-Small Cell Lung Cancer (NSCLC) in Japan
  • Market Size of Non-Small Cell Lung Cancer (NSCLC) by Therapies in Japan
• Market Drivers
• Market Barriers